First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
Titel:
First-in-human study of LY3039478, an oral Notch signaling inhibitor in advanced or metastatic cancer
Auteur:
Massard, C. Azaro, A. Soria, J.-C. Lassen, U. Le Tourneau, C. Sarker, D. Smith, C. Ohnmacht, U. Oakley, G. Patel, B.K.R. Yuen, E.S.M. Benhadji, K.A. Rodon, J.